RxDoctor Payments Data

Robert Kaplan, MD

Dermatology · Memphis, TNNPI 1750359543

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 401 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,201 and has fallen 72.6% since, to $604 in 2025.

$8,781in general payments, 2019–2025

Across 401 payments — averaging $21.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$2K
  • Novartis$1K
  • Mayne Pharma Commercial LLC$678
  • Sanofi$541
  • AbbVie$541
  • Dermavant Sciences, Inc.$536
  • plus $4K from 23 others

What the payments were for

  • Food & beverage$8,781100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,781 in reported general payments places this provider in the 75th percentile of 209 dermatology providers in Tennessee.

See all dermatology providers in Tennessee

Medicare billing

Part B allowed, 2024
$506,053
Medicare patients
943
Services billed
7,849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Valerate215$7,901
Fluocinonide155$7,554
Ketoconazole241$3,287
Mupirocin387$3,178
Clobetasol Propionate37$2,738
Tavaborole18$2,714
Mometasone Furoate122$2,714
Cephalexin212$1,895
Ciclopirox40$1,674
Metronidazole35$1,508
Alclometasone Dipropionate57$1,389
Doxycycline Hyclate38$1,204
Clindamycin Phosphate30$1,188
Triamcinolone Acetonide87$1,093
Tretinoin26$1,068

Paid to pharmacies, not to this prescriber.

Other dermatology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →